Announcement on Termination of Outward Investment
Filed with SSE · · 2 pages · Chinese
Nanjing Pharmaceutical Group Company Limited on 6ix
Earlier from Nanjing Pharmaceutical
- Announcement on Convening Performance Briefing for 2025 and Q1 2026
- Announcement on Resolutions of the 2025 Annual General Meeting
- Report for Q1 2026
- Announcement on Issuance Result of Phase VI Ultra-Short-Term Financing Bonds of 2026
- Announcement on Progress in Government’s Expropriation of Certain Real Estate and Land of the Company’s Tier-II Subsidiary
Later from Nanjing Pharmaceutical
- Announcement on Resolutions of the Extraordinary Meeting of the 10th Board of Directors
- Announcement on Outline of the Performance Briefing for 2025 and Q1 2026
- Announcement on Issuance Result of Phase I Medium-term Notes of 2026
- Announcement on Issuance Result of Phase VII Ultra-Short-Term Financing Bonds of 2026
- Announcement on the Redemption upon Maturity of Cash Management with Part of Temporarily Idle Raised Funds by the Company and the Continuation of Cash Management
Follow Nanjing Pharmaceutical into a list and get an email when it puts out news.
Follow Nanjing Pharmaceutical